Extended lymph node removal does not benefit patients with clinically localized muscle-invasive bladder cancer Results of the definitive SWOG S1011 phase 3 surgical trial, which also found increased ...

Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following ...

UC San Diego Health is the first health system in San Diego County to offer a new bladder-saving gene therapy to treat localized bladder cancer. The novel treatment is the first and only FDA-approved ...

TAR-200 demonstrated high DFS and bladder preservation rates in BCG-unresponsive, high-risk non-muscle-invasive bladder cancer with papillary-only disease. The phase 2b SunRISe-1 study showed over 80% ...

Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being over age 55. And the unfortunate reality is that women are often diagnosed at ...

Lucknow: Doctors at Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS) treated a rare, high-risk bladder tumour — urinary bladder para.